[1]Ng SC, Tang W, Ching JY, et al. Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study. Gastroenterology.2013;145(1):158-165.
[2]王玉芳,欧阳钦.3100例溃疡性结肠炎住院病例回顾分析[J].中华消化杂志,2006,26(6):368-372.
[3]Ventham NT,Kennedy NA, Nimmo ER, et al. Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics. Gastroenterology.2013;145(2):293-308.
[4]Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2014;gutjnl-2014- 307410.
[5]Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature.2012;491(7422):119-124.
[6]Anderson CA,Boucher G,Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet.2011; 43(3):246-252.
[7]Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut.2009; 58(8):1152-1167.
[8]Juyal G, Negi S, Sood A, et al. Genome-wide association scan in north Indians reveals three novel HLA-independent risk loci for ulcerative colitis. Gut., 2014,16.pii: gutjnl-2013- 306625.
[9]Palomino-Morales RJ, Oliver J, Gómez-García M, et al. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun.2009;10(4):356-364.
[10]Hoefkens E, Nys K, John JM, et al.Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stress. Autophagy.2013:9 (12):2046-2055.
[11]Mayer L, Kaser A, Blumberg RS. Dead on arrival: understanding the failure of CTLA4-immunoglobulin therapy in inflammatory bowel disease. Gastroenterology. 2012;143(1):13-17.
[12]Cooke J, Zhang H, Greger L,et al. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflamm Bowel Dis.2012;18(11):2128-2137.
[13]黄艳,卢圣锋,何苏云,等.组蛋白乙酰化与缺血性心肌病[J].中国老年学杂志,2014,34(8):2285-2288.
[14]Häsler R, Feng Z, Bäckdahl L, et al. A functional methylome map of ulcerative colitis. Genome Res.2012;22(11):2130-2137.
[15]Arasaradnam RP, Khoo K, Bradburn M, et al. DNA methylation of ESR-1 and N-33 in colorectal mucosa of patients with ulcerative colitis (UC). Epigenetics. 2010;5(5): 422-426.
[16]Tan M, Luo H, Lee S, et al. Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification. Cell.2011;146(6):1016-1028.
[17]Alenghat T, Osborne LC, Saenz SA, et al. Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature.2013;504(7478):153-157.
[18]Wang LS, Kuo CT, Stoner K, et al. Dietary black raspberries modulate DNA methylation in dextran sodium sulfate (DSS)-induced ulcerative colitis. Carcinogenesis. 2013;34(12): 2842-2850.
[19]Glauben R,Sonnenberg E,Zeitz M,et al.HDAC inhibitors in models of inflammation-related tumorigenesis. Cancer Lett. 2009;280(2):154-159.
[20]Lees CW, Barrett JC, Parkes M, et al. New IBD genetics: common pathways with other diseases. Gut.2011;60(12): 1739-1753.
[21]Nie L, Wu HJ, Hsu JM, et al. Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am J Transl Res. 2012;4(2):127-150.
[22]Wu F, Zikusoka M, Trindade A, et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology.2008;135(5):1624-1635.
[23]Chen WX, Ren LH, Shi RH. Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. World J Gastrointest Pathophysiol.2014;5(2):63-70.
[24]McKenna LB,Schug J,Vourekas A,et al.MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology. 2010;139(5):1654-1664.
[25]周鹏志,陈斌,胡品津,等.miR-19a对溃疡性结肠炎的作用机制[J]. 南方医科大学学报, 2013, 33(9):1325-1328.
[26]Koukos G,Polytarchou C,Kaplan JL,et al.MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology.2013;145(4):842-852.
[27]Takaishi H, Kanai T, Nakazawa A, et al. Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA):accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype. J Gastroenterol. 2012;47(9):969-977.
[28]Dhir M,Montgomery EA,Glöckner SC,et al.Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. J Gastrointest Surg. 2008;12(10):1745-1753. |